Sector Gamma As as of Sept. 30, 2019
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 34 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 11.9 | $70M | 1.4M | 50.71 | |
| Boston Scientific Corporation (BSX) | 7.6 | $45M | 1.1M | 40.69 | |
| Abbott Laboratories (ABT) | 7.6 | $45M | 537k | 83.67 | |
| Baxter International (BAX) | 7.0 | $41M | 472k | 87.47 | |
| Gilead Sciences (GILD) | 5.1 | $30M | 475k | 63.38 | |
| NuVasive | 5.0 | $30M | 468k | 63.38 | |
| Incyte Corporation (INCY) | 4.3 | $26M | 346k | 74.23 | |
| PerkinElmer (RVTY) | 4.3 | $26M | 300k | 85.17 | |
| Regeneron Pharmaceuticals (REGN) | 3.5 | $21M | 76k | 277.40 | |
| Agilent Technologies Inc C ommon (A) | 3.4 | $20M | 260k | 76.63 | |
| Anthem (ELV) | 3.0 | $18M | 75k | 240.10 | |
| Eli Lilly & Co. (LLY) | 2.9 | $17M | 152k | 111.83 | |
| Qiagen Nv | 2.7 | $16M | 485k | 32.97 | |
| Bio-Rad Laboratories (BIO) | 2.6 | $15M | 46k | 332.73 | |
| Perrigo Company (PRGO) | 2.4 | $14M | 258k | 55.89 | |
| Takeda Pharmaceutical (TAK) | 2.4 | $14M | 816k | 17.20 | |
| Bruker Corporation (BRKR) | 2.3 | $14M | 308k | 43.93 | |
| Biogen Idec (BIIB) | 2.1 | $12M | 52k | 232.82 | |
| United Therapeutics Corporation (UTHR) | 2.0 | $12M | 148k | 79.75 | |
| Humana (HUM) | 1.9 | $11M | 44k | 255.66 | |
| Elanco Animal Health (ELAN) | 1.9 | $11M | 417k | 26.59 | |
| Universal Health Services (UHS) | 1.6 | $9.6M | 65k | 148.74 | |
| Tenet Healthcare Corporation (THC) | 1.6 | $9.5M | 430k | 22.12 | |
| Cardinal Health (CAH) | 1.6 | $9.3M | 197k | 47.19 | |
| Alexion Pharmaceuticals | 1.5 | $8.8M | 90k | 97.94 | |
| Patterson Companies (PDCO) | 1.4 | $8.4M | 469k | 17.82 | |
| Ionis Pharmaceuticals (IONS) | 1.3 | $7.9M | 132k | 59.91 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $7.8M | 97k | 80.42 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $7.4M | 173k | 42.78 | |
| Ptc Therapeutics I (PTCT) | 0.7 | $4.1M | 121k | 33.82 | |
| Portola Pharmaceuticals | 0.6 | $3.4M | 126k | 26.82 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $3.3M | 103k | 32.40 | |
| Sangamo Biosciences (SGMO) | 0.4 | $2.3M | 252k | 9.05 | |
| Clovis Oncology | 0.3 | $1.7M | 431k | 3.93 |
